Filana Therapeutics FLNA
NASDAQ FLNA
$0.96 +0.02 (+1.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Short-term Investments (2010 - 2024)

Filana Therapeutics (FLNA) posted quarterly Short-term Investments of $40.0 million for Q3 2024, up 1805.67% quarter-over-quarter from $2.1 million in Q4 2016.

Filana Therapeutics (FLNA) Short-term Investments (2010 - 2024) Analysis & Trends

Filana Therapeutics' Short-term Investments history runs 8 years deep, the most recent figure standing at $40.0 million for Q3 2024.

  • In Q3 2024, Short-term Investments changed N/A year-over-year to $40.0 million; the TTM figure through Sep 2024 stood at $40.0 million (changed N/A YoY), while the FY2016 annual figure was $2.1 million, down 75.0% from the prior year.
  • Short-term Investments for Q3 2024 stood at $40.0 million, up from $2.1 million in the prior quarter.
  • The five-year high for Short-term Investments was $40.0 million in Q3 2024, with the low at $40.0 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Filana Therapeutics 46.00 Mn 46.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 40.00 Mn
Dec 31, 2016 2.10 Mn
Sep 30, 2016 550,000.00
Jun 30, 2016 3.48 Mn
Mar 31, 2016 1.50 Mn
Dec 31, 2015 8.40 Mn
Sep 30, 2015 900,000.00
Jun 30, 2015 950,000.00
Mar 31, 2015 8.40 Mn
Dec 31, 2014 4.85 Mn
Sep 30, 2014 1.10 Mn
Jun 30, 2014 250,000.00
Mar 31, 2014 1.25 Mn
Dec 31, 2013 1.25 Mn
Sep 30, 2013 1.30 Mn
Jun 30, 2013 1.30 Mn
Mar 31, 2013 2.80 Mn
Dec 31, 2012 6.90 Mn
Mar 31, 2012 22.12 Mn
Dec 31, 2011 24.99 Mn